PEAKS Studio 5.1 User's Manual

Total Page:16

File Type:pdf, Size:1020Kb

PEAKS Studio 5.1 User's Manual BIOINFORMATICS SOLUTIONS INC. PEAKS Studio 5.1 User’s Manual © Bioinformatics Solutions Inc. 470 Weber St. N. Suite 204 Waterloo, Ontario, Canada N2L 6J2 Phone 519-885-8288 • Fax 519-885-9075 Please contact BSI for questions or suggestions for improvement. 1. Introduction to PEAKS 5.1 ................................................................................6 1.1 Main Features............................................................................................................. 6 1.2 New Features in the PEAKS 5 Product Line .......................................................... 6 1.3 Workflow .................................................................................................................... 7 1.4 Guidelines for Using this Manual............................................................................. 7 1.5 Scope............................................................................................................................ 7 1.6 Service and Support................................................................................................... 7 2. Getting Started with PEAKS 5.1 .......................................................................8 2.1 Package Contents....................................................................................................... 8 2.2 System Requirements ................................................................................................ 8 2.2.1 Adjusting the Amount of Memory that PEAKS Uses ............................. 8 2.3 Installation for Windows Users ................................................................................ 9 2.4 Registering PEAKS.................................................................................................. 10 2.4.1 Registration Instructions (Internet Connection).................................... 10 2.4.2 Registration Instructions (No Internet Connection).............................. 11 2.4.3 Re-registration Instructions..................................................................... 14 2.5 Set up PEAKS Preferences ..................................................................................... 14 2.6 Set up PEAKS Configuration ................................................................................. 14 3. Quick Walkthrough ..........................................................................................15 3.1 Create a Sample Database....................................................................................... 15 3.2 Create a Project........................................................................................................ 15 3.3 Perform Data Refinement ....................................................................................... 17 3.4 Run de novo Sequencing.......................................................................................... 18 3.5 Run Protein Identification ...................................................................................... 21 3.6 Run PTM Finder...................................................................................................... 23 3.7 Run an inChorus Search ......................................................................................... 25 3.8 Perform a SPIDER Search...................................................................................... 30 4. Load Data...........................................................................................................33 4.1 Data Formats............................................................................................................ 33 4.2 Data Conversion....................................................................................................... 33 4.2.1 PEAKS Project Converter ....................................................................... 33 4.2.2 Agilent Data............................................................................................... 34 4.2.3 Applied Biosystems (WIFF)Data............................................................. 34 4.2.4 Applied Biosystems (4700/4800)Data ...................................................... 35 4.2.5 Bruker Data............................................................................................... 35 4.2.6 Shimadzu Data .......................................................................................... 35 4.2.7 Thermo Data.............................................................................................. 36 4.2.8 Varian Data ............................................................................................... 36 4.2.9 Waters/Micromass (MassLynx) Data ..................................................... 36 4.3 Create a New Project............................................................................................... 37 4.4 Add Data to an Existing Project............................................................................. 38 4.5 Open / Close a Project ............................................................................................. 39 4.6 Delete and Hide Results............................................................................................ 39 4.7 Change the Location of Saved Projects ................................................................. 39 4.8 Orienting Yourself ................................................................................................... 40 2 4.8.1 Project View Panel.................................................................................... 40 4.8.2 Properties Panel ........................................................................................ 40 4.8.3 Raw Spectrum View ................................................................................. 41 5. Data Refinement.................................................................................................43 5.1 Run Data Refine....................................................................................................... 43 5.2 Data Refinement Parameters.................................................................................. 44 5.2.1 Merging Scans ........................................................................................... 44 5.2.2 Precursor Charge Correction .................................................................. 44 5.2.3 Filtering MS/MS Scans............................................................................. 44 5.2.4 Preprocessing MS/MS Scans.................................................................... 44 5.3 Data Preprocessing Results..................................................................................... 44 6. de novo Sequencing ...........................................................................................45 6.1 Setting up Auto de novo Sequencing Parameters.................................................. 45 6.1.1 Mass Options ............................................................................................. 46 6.1.2 Enzyme Options ........................................................................................ 46 6.1.3 PTM Options ............................................................................................. 46 6.1.4 General Options ........................................................................................ 46 6.2 de novo Sequencing Results..................................................................................... 47 6.2.1 Peptide Candidates Frame....................................................................... 48 6.2.2 Ion Table Frame........................................................................................ 50 6.2.3 Spectrum View Frame.............................................................................. 50 6.2.4 Spectrum Alignment Frame..................................................................... 51 6.2.5 Survey Scan ............................................................................................... 51 6.2.6 Error Map.................................................................................................. 51 6.3 Manual de novo Sequencing.................................................................................... 51 6.3.1 Manual de novo Graphical User Interface.............................................. 51 6.3.2 Manual de novo Operations ..................................................................... 53 7. Database Search ................................................................................................58 7.1 Setting up Protein Identification Parameters........................................................ 58 7.1.1 Mass Options ............................................................................................. 59 7.1.2 Enzyme Options ........................................................................................ 59 7.1.3 General Options ........................................................................................ 59 7.1.4 PTM Options ............................................................................................. 60 7.1.5 Database Options ...................................................................................... 61 7.1.6 Advanced Options..................................................................................... 61 7.2 Protein Identification Results ................................................................................. 62 7.2.1 Peptide View.............................................................................................
Recommended publications
  • TV Universe—UK, Germany, Sweden: HOW PEOPLE WATCH TELEVISION TODAY Author: Colin Dixon, Founder and Chief Analyst, Nscreenmedia | 2019
    TV Universe—UK, Germany, Sweden: HOW PEOPLE WATCH TELEVISION TODAY Author: Colin Dixon, Founder and Chief Analyst, nScreenMedia | 2019 I NTRODUCTION Technology has become such a part of our daily lives that sometimes it seems that it is an end unto itself. However, in the world of the consumer, it has a particular role to play. Tim O’Reilly, who coined the term “open source,” put Online TV is now the second it this way: most popular source of “What technology does is create new opportunities to do a job that customers want done.”1 Home entertainment is most certainly a job that people “want done.” Ninety years ago, broadcast television television content in the UK, technology was the new opportunity to deliver it in an entirely new way.2 Based on the data from our most recent survey in Europe, the internet has become the next new opportunity to provide television entertainment to the home. Germany, and Sweden. Today, there are three primary sources of TV entertainment available to consumers: free-to-air (FTA), pay TV, and online TV. Free-to-air TV channels are typically received via an antenna but can also arrive over satellite and cable. Examples include BBC1, SVT1, and Das Erste. Pay TV services distribute linear TV over cable, satellite, and telco TV systems. Examples include Virgin Media, Sky Deutschland, and Com Hem. Online TV allows viewers to stream or download shows and movies over mobile and broadband data networks. Examples of services include Netflix, Now TV, and Amazon Prime Video. Just twelve years after Netflix first introduced streaming services, online TV has become the second most popular TV source in the UK, Germany, and Sweden.
    [Show full text]
  • Channel 5, Playground and MASTERPIECE on PBS Announce Cast for All Creatures Great and Small
    EMBARGOED UNTIL 7:01PM ET TUESDAY SEPTEMBER 24TH Channel 5, Playground And MASTERPIECE On PBS Announce Cast For All Creatures Great And Small Newcomer Nicholas Ralph to play beloved vet James Herriot opposite Samuel West, Anna Madeley, Callum Woodhouse and Rachel Shenton Channel 5, BAFTA and Golden Globe-winning production company Playground (Howards End, Wolf Hall) and MASTERPIECE on PBS today announced the casting of key roles for their upcoming adaptation of best-selling author James Herriot’s cherished collection of stories, written by Ben Vanstone (The Last Kingdom) and directed by Brian Percival (Downton Abbey). Exciting newcomer Nicholas Ralph will make his television debut as the iconic vet who became renowned for his inspiring compassion, humour and love of life. Samuel West (Mr. Selfridge, On Chesil Beach) joins as Siegfried Farnon, the wonderfully eccentric veteri- nary surgeon and proprietor of Skeldale House who reluctantly hires the recently qualified Herriot into his rural practice. Mrs Hall, the resident housekeeper and matriarch of Skeldale House will be played by Anna Madeley (The Child in Time, Patrick Melrose). Siegfried’s errant and charismatic younger brother, Tristan, will be played by Callum Woodhouse (The Durrells in Corfu). Rachel Shenton (Switched at Birth, White Gold) takes the role of Helen Alderson, an independent local farmer’s daughter who helps her father manage the family farm and care for her younger sister. “This is an exceptional cast made up of a wonderful mix of exciting new and established talent,” says executive producer Colin Callender. “Re-visiting the world of All Creatures Great and Small is like going home and re-discovering old friends whom we haven’t seen in years.
    [Show full text]
  • Response to House of Commons DCMS Select Committee on the Future of Public Service Broadcasting
    Response to House of Commons DCMS Select Committee inquiry on the Future of Public Service Broadcasting June 2020 Summary • The UK’s PSB system has contributed greatly to a wealth of high-quality diverse content which has enriched and enhanced the UK culturally and socially, and also grown our TV production sector into a world leader. • While technology has caused shifts in viewing habits and access to a wider range of services, the level of public investment plus the specific remits for the PSBs means they remain as important as ever. • PSB continues to draw large audiences and services such as the BBC have shown their value, particularly during the pandemic. • TAC believes that any changes to the system should be only to enhance it and allow it to remain strong and well-funded. It is inadvisable to remove or reduce any funding or services, given that technological platforms come and go, and the purely commercial broadcasting world is a continually changing market with an ever-shifting range of companies, content and services. Likewise, a shift to online only would leave some viewers without any access to a reliable TV PSB service. • Future policies regarding PSB should focus on maintaining and strengthening the system and would include measures such as: extending rules around PSB prominence; protecting TV Licence Fee funding (including retaining the status of evasion as a criminal offence); maintaining broadcast over the digital terrestrial network; and maintaining regulation by Ofcom. Introduction 1. TAC (Teledwyr Annibynol Cymru) represents the independent television production sector in Wales. Our sector is a highly important element of the creative industries in Wales and the UK overall, providing economic, social and cultural benefits through supplying creative content.
    [Show full text]
  • Media Nations: UK 2019
    Media nations: UK 2019 Published 7 August 2019 Overview This is Ofcom’s second annual Media Nations report. It reviews key trends in the television and online video sectors as well as the radio and other audio sectors. Accompanying this narrative report is an interactive report which includes an extensive range of data. There are also separate reports for Northern Ireland, Scotland and Wales. The Media Nations report is a reference publication for industry, policy makers, academics and consumers. This year’s publication is particularly important as it provides evidence to inform discussions around the future of public service broadcasting, supporting the nationwide forum which Ofcom launched in July 2019: Small Screen: Big Debate. We publish this report to support our regulatory goal to research markets and to remain at the forefront of technological understanding. It addresses the requirement to undertake and make public our consumer research (as set out in Sections 14 and 15 of the Communications Act 2003). It also meets the requirements on Ofcom under Section 358 of the Communications Act 2003 to publish an annual factual and statistical report on the TV and radio sector. This year we have structured the findings into four chapters. • The total video chapter looks at trends across all types of video including traditional broadcast TV, video-on-demand services and online video. • In the second chapter, we take a deeper look at public service broadcasting and some wider aspects of broadcast TV. • The third chapter is about online video. This is where we examine in greater depth subscription video on demand and YouTube.
    [Show full text]
  • Et Al., 1989; Reibnegger Et Survival Responses
    Oncogene (2002) 21, 1391 ± 1400 ã 2002 Nature Publishing Group All rights reserved 0950 ± 9232/02 $25.00 www.nature.com/onc Role of the AKT kinase in expansion of multiple myeloma clones: eects on cytokine-dependent proliferative and survival responses Jung-hsin Hsu1, Yijiang Shi1, Liping Hu1, Myrna Fisher1, Thomas F Franke2 and Alan Lichtenstein*,1 1Department of Medicine and Pathology, West LA VA-UCLA Medical Center and Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, CA 90073, USA; 2Department of Pharmacology, Columbia University, New York, NY 10032, USA IL-6 is an established growth factor for multiple bone marrow of myeloma patients and levels correlate myeloma tumor cells, stimulating proliferative and with disease activity (Bataille et al., 1989; Reibnegger et survival responses. Recent work indicates that IL-6 can al., 1991; (2) Monoclonal anti-IL-6 antibodies can activate the AKT kinase in myeloma cells. Thus, to test induce anti-tumor responses in patients (Klein et al., a potential role for AKT in IL-6-induced cellular 1991); Bataille et al., 1995), and; (3) IL-6 transgenic responses, we transfected myeloma cell lines with an mice are prone to developing MM (Suematsu et al., active `E40K' or dominant negative `PH' AKT construct 1992), while IL-6 knockout mice are resistant (Hilbert using an adenoviral vector. Transfection of the E40K et al., 1995). The source of IL-6 is from the marrow into myeloma cells resulted in enhanced tumor cell microenvironment which stimulates MM cells in a growth and expression of the PH dominant negative paracrine fashion (Klein et al., 1989).
    [Show full text]
  • Samsung TV Plus
    Samsung TV Plus Channel Descriptions | UK | 9th Dec 2020 Channel Description Info Samsung Name Logo Genre Summary TV Plus # Art/Music/Surf/Skate/Snow — the five pillars of the Absinthe Films Sports & Outdoors 4071 foundation that is boardsport culture. Action Movies – Rakuten TV Movies Movies to keep you on the edge of your seat. 4504 The crown jewels of drama, All Drama is brimming with All Drama Entertainment 4256 classic TV from the last decade. In Big Name, discover fascinating biopics that retrace the history of the great names of humanity. (Re) discover the Big Name Entertainment 4257 history of those who have stood out notably for our greatest good ... or our greatest misfortune. Bloomberg TV+ UHD delivers Live 24x7 global business and markets news, data, analysis, and stories from Bloomberg Bloomberg TV+ News 4007 News and Businessweek – available in a 4K ultra high definition (UHD) viewing experience. Samsung brings you a mix of great UK and US comedy content, from Russell Howard telling you Good News to Comedy Movies 4001 chuckling along to the best bits of Taskmaster. Comedy – It’s a Laughing Matter! Comedy Movies – Rakuten Movies Amusing, lighthearted movies to keep your spirits high. 4002 TV Deluxe Lounge – the relaxed sound for a good feeling. Your time, your break: to come down, take a deep breath and take Deluxe Lounge HD Music 4451 a break. Urbanauts, lounge lizards meet lounge-like tracks and smooth bar-grooves - the lounge mix. Head off, music on! The world’s best platform for quality short form entertainment! Watch short movies, documentaries, comedies discover.film Movies 4507 & dramas, featuring known Hollywood stars and emerging talent.
    [Show full text]
  • BBC Iplayer Competition Assessment Research Report Prepared for Ofcom June 2019 Contents
    BBC iPlayer Competition Assessment Research Report Prepared for Ofcom June 2019 Contents 1 Background and methodology 3 2 Executive summary 9 3 The TV and VOD landscape 12 4 The scenarios 23 5 Impression of BBC changes 58 6 Infrequent/Non-internet users 62 7 Appendix 64 2 1 Background and methodology Research objectives Ofcom is seeking to better understand the potential impact of the BBC’s proposed changes on the consumption of other video-on-demand (VOD) services and linear TV channels Developing a picture of the Assessing the potential current media and viewing Understanding the attitude behavioural changes caused by a consumption of internet users in towards the proposed changes new BBC iPlayer offer the UK 4 Our recommended approach was to gather the views of internet users and those not online/online infrequently separately This allowed us to use the most efficient, and most cost effective, methods to reach each group within the desired timings. Internet Users Those not online/online infrequently Reached through N = 4,000 UK weekly F2F Kantar internet users (16+) CAPI Omnibus Online N = 2,060 UK Questionnaire adults (16+) per survey Internet users were asked detailed Infrequent/Non-internet users were asked a shorter, questions about their TV and VOD usage more targeted survey to ensure their views about as well as 3 scenarios to gauge their the proposed BBC iPlayer changes were captured reaction to the proposed BBC iPlayer without putting them through a lengthy survey on a changes service they might not be familiar with 5 Questionnaire
    [Show full text]
  • Expression of VEGF and Its Receptors by Myeloma Cells S Kumar1, TE Witzig1, M Timm1, J Haug1, L Wellik1, R Fonseca1, PR Greipp1 and SV Rajkumar1
    Leukemia (2003) 17, 2025–2031 & 2003 Nature Publishing Group All rights reserved 0887-6924/03 $25.00 www.nature.com/leu Expression of VEGF and its receptors by myeloma cells S Kumar1, TE Witzig1, M Timm1, J Haug1, L Wellik1, R Fonseca1, PR Greipp1 and SV Rajkumar1 1Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA Angiogenesis or new vessel formation is an essential compo- and is being increasingly recognized.4 Increasing levels of tumor nent in the growth and progression of neoplasms and there is angiogenesis has been associated with poor prognosis for a growing evidence of its importance in hematological malig- nancies including multiple myeloma (MM). Vascular endothelial variety of hematological malignancies as well as solid tumors. growth factor (VEGF) is believed to play a role in tumor As in solid tumors, new vessel formation (occurring in the bone angiogenesis. We studied the expression of VEGF and its marrow) seems to play an important role in the pathophysiology receptors (VEGFR1 or Flt-1 and VEGFR2 or Flk-1/KDR) by of myeloma,5–8 leukemias9,10 and in myelofibrosis.11 Increased myeloma cell lines and plasma cells isolated from patients, bone marrow microvessel density in patients with myeloma using different methods. VEGF expression by the plasma cells appears to be a powerful prognostic indicator.7 was demonstrated by immunohistochemistry in 18 of 20 patients with MM. Enzyme-linked immunosorbent assay de- Various cytokines have been invoked as being responsible for monstrated VEGF secretion in all six different myeloma cell driving the process of neovascularization seen in the setting 12 lines studied.
    [Show full text]
  • FREEVIEW DTT Multiplexes (UK Inc NI) Incorporating Planned Local TV and Temporary HD Muxes
    As at 4 Decmber 2017 FREEVIEW DTT Multiplexes (UK inc NI) incorporating planned Local TV and Temporary HD muxes 3PSB: Available from all transmitters (*primary and relay) 3 COM: From *80 primary transmitters only Temporary HD - 30 primary transmitters BBC A (PSB1) BBC A (PSB1) continued BBC B (PSB3) HD SDN (COM4) ARQIVA A (COM5) ARQIVA B (COM6) ARQIVA C (COM7) HD ARQIVA D (COM8) LCN LCN LCN LCN LCN LCN LCN LCN 1 BBC ONE 45 Film4+1 10 ITV3 11 Pick 18 4 Music 56 5USA+1 (from 6pm) 40 Rocks & Co 1 BBC RADIO: 1 BBC ONE NI Cambridge, Lincolnshire, 101 BBC 1 Scot HD 16 QVC 12 Dave 19 Yesterday 57 VIVA (5am-6pm) 55 5STAR+1 722 Merseyside, Oxford, 1 BBC ONE Scot Solent, Somerset, Surrey, 101 BBC 1 Wales HD 20 Drama 17 Really 22 Ideal World 64 CBS Action +1 86 More4+1 Tyne Tees, WM 1 BBC ONE Wales 101 BBC ONE HD 21 5 USA 23 Create & Craft 25 Home 67 CBS Reality+1 95 Freesports 2 BBC TWO 101 BBC ONE NI HD 26 ITVBe 29 E4+1 31 5Spike 82 Vintage TV 96 Forces TV BBC RADIO: 2 BBC TWO NI Essex, Northampton, 102 BBC TWO HD 27 ITV2 +1 32 Sony Movie Ch 35 QVC Beauty 87 Keep It Country 111 QVC HD 734 Sheffield, Stoke, Solent 2 BBC TWO Scot 103 ITV HD 28 E4 (Wales only) 38 Quest Red 36 QVC Style 106 BBC FOUR HD 112 QVC Beauty HD for Dorset, 2 BBC TWO Wales 103 ITV Wales HD 30 5 STAR 41 Food Network 39 CBS Action 107 BBC NEWS HD 115 BT Showcase HD 7 BBC ALBA (Scot only) 103 STV HD 34 ITV3+1 (18:00-00:00) 43 Gems TV 42 Travel Channel 108 Al Jazeera Eng HD BBC RADIO: 9 BBC FOUR 735 103 UTV HD 37 QUEST 46 Challenge 47 4seven 109 Channel 4+1HD Derby, Gloucestershire
    [Show full text]
  • Changes to BBC Iplayer: Competition Assessment
    CHANGES TO BBC IPLAYER Competition assessment April 2019 Clive Kenny [email protected] Frontier Economics Ltd is a member of the Frontier Economics network, which consists of two separate companies based in Europe (Frontier Economics Ltd) and Australia (Frontier Economics Pty Ltd). Both companies are independently owned, and legal commitments entered into by one company do not impose any obligations on the other company in the network. All views expressed in this document are the views of Frontier Economics Ltd. CHANGES TO BBC IPLAYER CONTENTS Executive Summary 5 1 Introduction 18 1.1 Structure of this report 18 2 Framework for assessing the impact of the BBC iPlayer changes on competition 20 2.1 Introduction 20 2.2 Regulatory framework to assess changes to the BBC’s services 20 2.3 Analytical framework for the assessment of crowding out 24 2.4 Analytical framework for the assessment of scope for harm to competition elsewhere in the supply chain 28 3 The competitive context for the proposed changes to BBC iPlayer 30 3.1 The audio-visual sector is characterised by constant innovation 30 3.2 VoD competes with linear broadcasters, as well as newer audio-visual suppliers 31 3.3 Technological advances have led to convergence between different forms of content 33 3.4 Entrant broadcasters have put pressure on broadcasters to compete and innovate 33 3.5 Conclusion on sector wide trends 35 4 Suppliers affected by the changes to BBC iPlayer 37 4.1 Introduction 37 4.2 The BBC iPlayer’s role in the TV value chain 37 4.3 Identifying
    [Show full text]
  • Including Sky Go, Vod, Advance, One Campaign and Adsmart Platforms
    SKY STANDARD TERMS AND CONDITIONS FOR LONG FORM CONTENT (INCLUDING SKY GO, VOD, ADVANCE, ONE CAMPAIGN AND ADSMART PLATFORMS) 1. DEFINITIONS “CAP Code” means the Committee of Advertising Practice (Non- Broadcast) Code and accompanying guidance, (as amended or 1.1 In these Terms and Conditions, the following words and superseded from time to time); expressions shall have the following meanings unless the context otherwise requires: “CHAPS” means Clearing House Automated Payments System; “Advertisement” means the Creative delivered to Sky and “Clearcast” means Clearcast Limited or any superseding body; intended for delivery (either on a targeted or untargeted “Clear Working Days” means a number of consecutive Working Days, basis) by any means across any of the Sky Platforms that excluding the first day and the last day; distribute Long Form Content; “Client” means (a) the Agency acting on behalf of the Advertiser; (b) “Advertiser” means the advertiser specified in the Booking; where there is no Agency, the Advertiser; or both the Agency and the “Affiliate” in relation to any Party, any person, company, Advertiser together; association or other separate legal entity which, directly or “Control” means the power of a person, company, association or indirectly: (a) is Controlled by that Party; (b) Controls that other separate legal entity to secure (whether by the holding of Party; or (c) is under substantially common Control with that shares, possession of voting rights or by virtue of any powers Party; conferred by articles of association,
    [Show full text]
  • All Creatures Great and Small
    MASTERPIECE on PBS to Co-Produce Playground’s new James Herriot adaptation ALL CREATURES GREAT AND SMALL Boston, MA; June 27, 2019 - MASTERPIECE on PBS will co-produce All Creatures Great and Small, a brand new adaptation based on best-selling author James Herriot’s cherished and iconic collection of stories. The series is a production from BAFTA and Golden Globe®-winning production company Playground (Howards End, Wolf Hall). Channel 5 in the UK commissioned the series and All3Media will distribute interna- tionally.The production will also receive funding and support from Screen Yorkshire. All Creatures Great and Small will shoot on location in Yorkshire, England, as 2020 sees the 50th anniversary of the original publication of the much-loved books. The production, a six-part series plus a Christmas special, will be produced by Richard Burrell (New Tricks, Silent Witness). Executive Producers are Colin Callender and Melissa Gallant for Playground, Hugo Heppell for Screen Yorkshire and Rebecca Eaton for MASTERPIECE. MASTERPIECE on PBS is presented by WGBH Boston. Ben Vanstone (The Last Kingdom) is lead writer and Executive Producer and Brian Percival (Downton Abbey) is lead director. Since their first publication in 1970, the beloved books of James Alfred Wight, published under the pen name James Herriot, have held a special place in people’s hearts throughout the world. Chronicling the heartwarming and humorous adventures of a young country vet, the books introduced readers to his unconventional mentor and the cast of farmers and townsfolk who lived and worked in the Yorkshire Dales in the 1930s. This new adaptation will preserve the rich spirit, tone and values of Herriot’s iconic characters and stories and will bring to life his sharply observed, entertaining and incredibly funny tales of country life in the North of England for a modern audi- ence, introducing a new generation to his life-affirming stories.
    [Show full text]